2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
Închide
Conţinutul numărului revistei
Articolul precedent
Articolul urmator
233 0
SM ISO690:2012
LYON, Alexander Richard, LOPEZ-FERNANDE, Teresa, COUCH, Liam Steven, NOI, Autori, BURSACOVSCHI, Daniela. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). In: European Heart Journal, 2022, vol. 43, pp. 4229-4361. ISSN 0195-668X. DOI: https://doi.org/10.1093/eurheartj/ehac244
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
European Heart Journal
Volumul 43 / 2022 / ISSN 0195-668X

2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)

DOI:https://doi.org/10.1093/eurheartj/ehac244

Pag. 4229-4361

Lyon Alexander Richard1, Lopez-Fernande Teresa2, Couch Liam Steven3, Noi Autori, Bursacovschi Daniela4
 
1 Imperial College London,
2 La Paz University Hospital, Madrid,
3 King's College London,
4 Moldavian Society of Cardiology
 
 
Disponibil în IBN: 11 iunie 2023


Cuvinte-cheie
Antineoplastic Agents, Heart, hematology, Humans, Medical Oncology, Neoplasms, Radiation oncology